While three-quarters (76 per cent) of U.S. employers say they provide coverage of glucagon-like peptide-1 drugs for diabetes management, about a quarter (27 per cent) provide coverage of these drugs for weight loss, according to a new survey by the International Foundation of Employee Benefit Plans. The survey, which polled more than 200 U.S. benefits […]
Half (51 per cent) of plan members say the coverage levels of at least one of their health benefits limit their ability to seek necessary treatment, jumping to 84 per cent among those with a major injury in the past 12 months, according to the 2023 Benefits Canada Healthcare Survey. It found this percentage increased […]
A recent report by the Patented Medicine Prices Review Board shows increased growth for private drug plan costs but promising pharmaceutical innovation, says Joe Farago, executive director of private payers and investment at Innovative Medicines Canada. The report also found the number of new medicines launched in Canada was higher than the median for Organisation for […]
The majority of U.S. workers who say they understand their workplace benefits plan are happier (76 per cent) and have a greater sense of overall stability at work (82 per cent) than those who don’t understand their benefits (47 per cent and 52 per cent, respectively), according to a new survey by MetLife Inc. The […]
The costs of U.S. employer-sponsored medical benefits are expected to rise seven per cent in 2024, according to a new survey by the International Foundation of Employee Benefit Plans. The survey found 79 per cent of U.S. employers’ benefits plans are self-funded (with or without stop-loss coverage), while 21 per cent are fully insured. The […]